{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"RAGEback: Minh Le Cong, Verapamil and SVT","description":"The discussion of verapamil as an option for the treatment of supraventricular tachycardia (SVT) in&amp;nbsp;RAGE Session Two&amp;nbsp;went off like a fire cracker in the FOAM world. In this RAGEback, Minh Le Cong from the&amp;nbsp;PHARM&amp;nbsp;podcast explains why the RAGE discussion is not going to change his practice, which is to use adenosine as a first line agent. This is followed by a response by RAGErs Karel and Cliff. You \u2014 the listener \u2014 are left to make up your own mind about which patients (if any) you\u2019ll consider verapamil as an option. ","author_name":"The RAGE Podcast - The Resuscitationist's Awesome Guide to Everything","author_url":"http:\/\/ragepodcast.com\/","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/2707456\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/item\/2707456"}